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Abstract
Primary microcephaly (PM) is characterized by a small head since birth and is vastly
heterogeneous both genetically and phenotypically. While most cases are monogenic,
genetic interactions between Aspm and Wdr62 have recently been described in a
mouse model of PM. Here, we used two complementary, holistic in vivo approaches:
high throughput DNA sequencing of multiple PM genes in human patients with PM,
and genome‐edited zebrafish modeling for the digenic inheritance of PM. Exomes of
patients with PM showed a significant burden of variants in 75 PM genes, that
persisted after removing monogenic causes of PM (e.g., biallelic pathogenic variants in
CEP152). This observation was replicated in an independent cohort of patients with
PM, where a PM gene panel showed in addition that the burden was carried by six
centrosomal genes. Allelic frequencies were consistent with digenic inheritance. In
zebrafish, non‐centrosomal gene casc5 −/− produced a severe PM phenotype, that
was not modified by centrosomal genes aspm or wdr62 invalidation. A digenic,
quadriallelic PM phenotype was produced by aspm and wdr62. Our observations
provide strong evidence for digenic inheritance of human PM, involving centrosomal
© 2019 The Authors. Human Mutation Published by Wiley Periodicals LLC
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genes. Absence of genetic interaction between casc5 and aspm or wdr62 further
delineates centrosomal and non‐centrosomal pathways in PM.
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1 | INTRODUCTION
Apparently Mendelian disorders can sometimes be better explained by
an oligogenic inheritance model than by a canonical monogenic model,
especially in the presence of incomplete penetrance, variable expres-
sivity or locus heterogeneity (Gazzo et al., 2017). Digenic inheritance is
the simplest form of oligogenic inheritance and refers to disorders
resulting from pathogenic variants at two distinct loci (Lupski, 2012).
True digenic inheritance requires the presence of variants at two
independent loci to trigger the disease, while composite class
inheritance refers to Mendelizing variants with modifiers (Papadimitriou
et al., 2019). Examples of true digenic inheritance in human pathology
include facioscapulohumeral muscular dystrophy Type 2 (Lemmers
et al., 2012) or midline craniosynostosis (Timberlake et al., 2016). By
contrast, dual molecular diagnosis refers to the aggregation, in a single
individual, of two independent phenotypes, each caused by (a) variant(s)
at a single locus (Posey et al., 2017). Dual diagnoses may be difficult to
distinguish from digenic inheritance when the two phenotypes
extensively overlap (Papadimitriou et al., 2019), but they are distinct
from a functional point of view. Digenic inheritance, but not dual
diagnoses, indicates a functional relationship between two loci, including
protein–protein interaction, protein–DNA interaction, or a shared
pathway, allowing for synergistic potentiation of alleles at the two loci
(Schäffer, 2013). Digenic inheritance encompasses several models of
allele combinations. The double heterozygosity model consists of
heterozygous pathogenic variants at two loci. The triallelic model
consists of biallelic pathogenic variants at one locus and a heterozygous
pathogenic variant at another locus (Katsanis et al., 2001). The
quadriallelic model consists of biallelic pathogenic variants at two loci.
Evidence of digenic inheritance is provided by protein–protein or
protein–DNA interaction, segregation of the phenotype in the family
and/or functional studies including animal models (Gazzo et al., 2016).
Genetic interactions have recently been described in a mouse model of
primary microcephaly (PM) caused by Aspm and Wdr62 (Jayaraman
et al., 2016), possibly indicating a composite class of digenic inheritance.
PM is an important and heterogeneous group of disorders of
brain development that results from insufficient production of
mature neurons during neurogenesis. Human PM is characterized
by a small occipito‐frontal circumference (OFC) since birth, with a
final head size in the adult ranging from −3 to −10 standard
deviations (SDs) below the mean. Nonsyndromic (microcephaly
primary hereditary [MCPH]) and syndromic (e.g., Seckel syndrome;
Meier–Gorlin syndrome; MOPD2; PM with diabetes) forms are
known. PM is mainly autosomal recessive, but the causing gene can
be identified in fewer than 50% of patients. Some forms of PM are
furthermore associated with anomalies of neuron migration (Woods
& Basto, 2014). PM is a model disease for the study of brain growth
and of neuronal organization in the human cerebral cortex.
Eighteen genes have been reported to cause MCPH (Naveed et al.,
2018). ASPM is the most common, followed by WDR62 (Létard et al.,
2018). Many PM‐causing gene products, including ASPM and WDR62,
are localized at the centrosome during interphase or spindle pole
during mitosis and are hence believed to cause PM by a common,
centrosomal mechanism (Barbelanne & Tsang, 2014; Megraw,
Sharkey, & Nowakowski, 2011). The centrosome, however, fails to
account for all PM‐causing genes, leaving room for at least two other
mechanisms (Duerinckx & Abramowicz, 2018). First, aberrant mitotic
checkpoint activity, which could deplete the final number of neurons
by reducing cell proliferation and initiating apoptosis (Zhou & Elledge,
2000), is the likely PM‐causing mechanism with pathogenic variants in
CASC5, directly required for the spindle assembly checkpoint
(Kiyomitsu, Obuse, & Yanagida, 2007) or pathogenic variants in genes
causing DNA replication stress (Zeman & Cimprich, 2014). Second,
aberrant regulation of mRNA translation inducing apoptosis in neural
progenitors is the likely mechanism of PM associated with a growing
number of genes, including TRMT10A (Igoillo‐Esteve et al., 2013).
In experimental PM, Aspm −/− mice showed a modest reduction
in brain size, which was strongly enhanced by an additional
heterozygous Wdr62 +/− pathogenic variant. The quadriallelic Aspm
−/− Wdr62 −/− mice presented with embryonic lethality. Besides
this genetic interaction, Aspm and Wdr62 proteins were shown to
physically interact at the mother centriole with the mediation of
Cep63, highlighting the role of these proteins in centriole duplica-
tion, and presenting PM as a “centriolopathy” (Jayaraman et al.,
2016).
It remains to be determined whether digenic/oligogenic inheritance
of PM applies to humans or not, and it would be extremely interesting to
demonstrate it. Better understanding the complex background of the PM
phenotype would help to find a molecular diagnosis in a higher proportion
of patients and would improve genetic counseling. Moreover, a
systematic search for digenic or oligogenic inheritance has the potential
to categorize mutually interacting genes, giving better insight on the
cellular mechanisms implicated in PM, delineating several functional
pathways, centriolar, and non‐centriolar. In the present study, we aimed
at better understanding the complex genetic background of apparently
Mendelian PM. For this purpose, we used two complementary, holistic, in
vivo approaches: high throughput DNA sequencing of multiple PM genes
in human PM patients, and genome‐edited zebrafish for modeling digenic
inheritance of PM, crossing fish for binary combinations of three genes:
two centrosomal (aspm and wdr62) and one non‐centrosomal (casc5).
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2 | MATERIALS AND METHODS
2.1 | Editorial policies and ethical considerations
All procedures complied with the ethical guidelines of Hôpital Erasme
—Université Libre de Bruxelles, whose Ethics Committee approved
our study under reference P2016/199 (Ethics Committee Erasme
Hospital, OMO21). Informed consent was obtained from the
patientʼs representatives.
All zebrafish husbandry and experiments were performed under
standard conditions in accordance with institutional (Université Libre
de Bruxelles) and national ethical and animal welfare guidelines and
regulation.
2.2 | Patients
The recruited patients with PM had an OFC smaller than 2 SD below
the age‐ and sex‐related mean at birth and/or smaller than 3 SD after
age 1 year. They were referred to two reference genetic centers.
Clinical information was obtained by the referring geneticist or
pediatrician. The first patients’ cohort (exome cohort) consisted of 47
PM patients and 140 control patients. The controls were in‐house
patients affected by non‐neurological disorders: cardiac arrhythmia,
renal graft tolerance, renal diseases, fertility problems, and also
normal parents of normocephalic probands in a trio cohort. The
replication cohort (gene panel cohort) consisted of 64 PM patients
and 63 control patients, tested for recurrent fever syndromes.
Indeed, our gene panel capture method included genes for PM,
inherited fevers, as well as other pathologies including pulmonary
arterial hypertension.
2.3 | High throughput sequencing
Patients’ DNA samples from the exome cohort were enriched for
exonic sequences, and patients’ DNA samples from the gene panel
cohort were enriched for exonic sequences of 14 PM genes as well as
10 other, non‐neural genes. For exome sequencing, the DNA capture
kit and the sequencing platform varied according to the reference
genetic center and the time of the analysis. The different sequencing
platforms were Beijing Genomics Institute, China (Illumina HiSeq
2000); AROS applied biotechnology, Denmark (Illumina HiSeq 2000);
IntegraGen, Evry, France (Illumina HiSeq 2000); and BRIGHTcore
BRussels Interuniversity Genomics High Throughput core, Brussels,
Belgium (Illumina HiSeq 1500). The five DNA capture kits used were
Illumina TruSeq ExomeTarget, NimbleGen Seqcap EZ v3, NimbleGen
Seqcap EZ v5, Agilent SureSelect All Exon v1 and Agilent SureSelect
All Exon v5. For the gene panel cohort, exonic sequences were
enriched using SeqCap EZ Choice NimbleGen Roche, and sequencing
was performed on a MiSeq Illumina sequencer at the molecular
genetic laboratory of Erasme Hospital, Brussels, Belgium. The high
throughput sequencing pipelines (exome and gene panel) are
described in Supplemental Methods. The mean coverage per patient
was 85X in the exome cohort, and >200X in the gene panel cohort.
2.4 | Variants pathogenicity classification
ACMG guidelines (Richards et al., 2015) were followed for variant
pathogenicity classification. Pathogenic (Class 5) and likely pathogenic
(Class 4) variants were considered as Mendelizing pathogenic variants.
Familial segregation of the Mendelizing variants was checked using
Sanger sequencing to demonstrate trans configuration in the auto-
somal recessive cases and de novo inheritance in the autosomal
dominant cases. All variants reported in this manuscript have been
submitted to the ClinVar database (https://www.ncbi.nlm.nih.gov/
clinvar/; ClinVar accessions SCV000998479‐SCV000998508).
2.5 | Mutation burden tests
Variants were filtered for quality criteria (pass GATK (DePristo et al.,
2011) standard filter, read depth ≥10), allelic frequency (based on the
maximum minor allele frequency found in ExAC (Lek et al., 2016), 1,000
G (TheGenomes Project Consortium, 2015 1000), ESP6500 (https://evs.
gs.washington.edu/EVS/; source: dbNSFP2.8), GoNL r5 (Genome of the
Netherlands Consortium, 2014), ARIC5606 (https://sites.cscc.unc.edu/
aric/), and our in‐house database), and for functional impact (nonsynon-
ymous or splice junction effect, using snpeff_effect from SnpEff (Cingolani
et al., 2012)).
Five different exome DNA capture kits were used for exome
sequencing (see above). The intersection of the five different kits was
examined, and only those variants included in the intersection of the
bed files were considered for mutation burden testing. This approach
reduced the total number of variants by a factor two.
PubMed (https://www.ncbi.nlm.nih.gov/pmc/) and Online Mendelian
Inheritance in Man (https://www.omim.org/), as accessed on October 03,
2017, were used to select the genes known to cause human PM,
establishing a set of 75 PM genes (ANKLE2, ARHGAP11B, ASPM, ATR,
ATRIP, BLM, BRAT1, BUB1B, CASC5, CASK, CDC6, CDK5RAP2, CDK6,
CDT1, CENPE, CENPF, CENPJ, CEP135, CEP152, CEP250, CEP63, CIT,
COX7B, CTIP, DNA2, DONSON, DYRK1A, EFTUD2, EIF2AK3, ERCC3,
ERCC4, ERCC5, ERCC6, ERCC8, IER3IP1, KIF11, KMT2B, LIG4, MCPH1,
MFSD2A, MYCN, NBS1, NDE1, NIN, NIPBL, NSMCE2, ORC1, ORC4, ORC6,
PCNT, PHC1, PLK4, PNKP, RAD50, RNU4ATAC, SASS6, SLC25A19, SLC9A6,
SMC1A, SMC3, STAMBP, STIL, TRAIP, TRMT10A, TUBA1A, TUBB, TUBB2B,
TUBB3, TUBG1, TUBGCP4, TUBGCP6, UBE3A, WDR62, ZEB2, ZNF335). As
controls, we used 1,926 housekeeping genes identified in at least seven
different studies (detective breadth ≥7; Zhang, Akintola, Liu, & Sun,
2016). For the gene panel data, the selection was defined by our DNA
capture kit targeting 14 PMs genes (ASPM, CASC5, CDK5RAP2, CENPJ,
CEP135, CEP152, MCPH1, ORC1, ORC4, ORC6, PCNT, STIL, TRMT10A,
WDR62), as well as non‐neural genes involved in diagnostic work‐ups of
other pathologies, for example, pulmonary arterial hypertension. The 14
PM genes included six PMs genes expressed at the centrosome (ASPM,
CDK5RAP2, CENPJ, CEP135, CEP152, andWDR62). Ten non‐neural genes
were selected as control genes (ACVRL1, BMPR1B, BMPR2, CAV1, ENG,
KCNK3, LTBP2, SLC4A11, SMAD4, SMAD9).
Mutation burden tests were programmed in‐house using R
coding. For each patient, the number of allelic variants in PM genes
was counted, homozygous variants counting as two allelic variants.
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For each PM gene, the number of allelic variants in the case or
control group was counted, and this number was divided by the
number of patients in the group.
In a permutation test, 10,000 random subsets of 75 housekeeping
genes were selected among the 1,926 housekeeping genes (Zhang
et al., 2016).
2.6 | Zebrafish invalidations
Zebrafish orthology search and invalidation using transcription
activator‐like effector nucleases targeting aspm, casc5, and wdr62
are described in Supplemental Methods. Zebrafish were maintained,
bred, and raised at 28°C under standard conditions. For each
targeted gene, at least two fish lines were obtained, harboring
different pathogenic variants (Table S1).
2.7 | Zebrafish genotyping
The primers designed for the polymerase chain reaction are shown in
Table S1. Detailed information on zebrafish genotyping is given in
Supplemental Methods.
2.8 | Zebrafish live imaging
Live imaging was performed with a S8APO microscope (Leica), with a
×20 magnification for the whole body pictures and a ×40 magnifica-
tion for the head pictures. Four to five days post fertilization (dpf)
zebrafish larvae were anaesthetized in 0.02% tricaine, and placed on
a Petri dish in a V‐shaped 3% agarose mold (Adaptive Science Tools
TU‐1). Leica Application Suite V4.6 was used to analyze the pictures
and take the measurements. Body length was the total length of the
larva. Head area was measured on a dorsal view picture as previously
shown (Brooks et al., 2014).
2.9 | Zebrafish experiments
Second generation (F2) heterozygous mutant fish were used for the
experiments. First, each mutant line was studied separately to
observe the phenotype of monogenic mutant fish. In a second step,
F2 adult fish heterozygous for two different genes were crossed
together and their progeny was studied. Part of the progeny was
raised to adulthood to maintain the double heterozygous strains. In a
third step, these double heterozygous fish were crossed together and
their progeny was studied (Figure S1).
For each experiment, adult fish were crossed, four to five dpf
zebrafish larvae were photographed and then directly put in tubes
for genotyping. The association between phenotype and genotype
was made a posteriori.
2.10 | Statistical methods
For the mutation burden test, the number of variants in the cases and in
the controls were compared using a nonparametric Wilcoxon test with
correction for ties. A permutation test with 10,000 selections of
housekeeping genes was performed to exclude the effect of chance in
PM gene selection. A mutation burden was measured and the Wilcoxon
statistic for independent samples was calculated for each of the 10,000
selections. The number of subsets of housekeeping genes yielding a
Wilcoxon statistic higher than for the PM genes was counted, and this
number divided by 10,000 was the p value of the permutation test.
For the zebrafish experiments, homozygous mutant larvae were
compared to the heterozygous and to the wildtype larvae with the
nonparametric Kruskal–Wallis test, followed by a Dunnʼs posttest.
The tests were considered statistically significant when p< .05. All
statistical tests were two‐tailed. They were performed using R software.
3 | RESULTS
3.1 | Patients with PM carry coding variants in 75
PM genes beyond Mendelian inheritance
We sequenced the exome of 47 PM probands. A monogenic cause of
PM, for example, biallelic pathogenic variants in CEP152, was identified
in the 75 PM genes in nine of the 47 patients (Table 1). We then
compared the burden of variants in 75 PM genes, in the 47 PM patients
and 140 control patients with non‐neurological disorders. The variants
were filtered as described in the Methods section, for various allelic
frequencies (0.5, 1, 3, and 5%). A statistically significant burden was
found in patients with PM, over the whole range of allelic frequencies
(Table S2A). As this result did not rule out a strictly monogenic model of
PM inheritance, we then removed from the analysis all the variants
identified as monogenic causes of PM (16 alleles, see Table 1). Even
without those causal variants, the patients with PM showed a higher
number of allelic variants in the 75 PM genes than the control patients,
for allelic frequencies of 5% or less (Figure 1), with a similar trend at
smaller allelic frequency cut‐offs. The statistics for each allelic frequency
are shown in Table S2B.
In parallel, we measured the burden of allelic variants in 75
control genes (housekeeping genes) among PM and control patients
(allelic frequency <5%), and observed no significant difference
between the two groups (Figure 1). To exclude the effect of chance
in the selection of the control genes, 10,000 permutations were
performed with 75 randomly chosen housekeeping genes (allelic
frequency <5%). Only 98 random selections of housekeeping genes
gave a higher value of the Wilcoxon statistic than with the PM genes
(p value of the permutation test 0.010). This means that we only have
a 1% chance to be wrong in concluding that the difference between
cases and controls was not due to chance in control gene selection.
Results from this first cohort thus showed that patients with PM
carry a significant burden of variants in 75 PM genes, even after
removal of the highly penetrant, Mendelizing variants.
3.2 | A replication cohort of patients with PM
shows a burden of variants in six centrosomal genes
As a replication cohort, we then studied 64 unrelated patients with
PM who underwent a diagnostic‐grade panel sequencing of 14 PM
genes with very high coverage (see Supplemental methods). Eight of
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the 64 patients were identified with a monogenic cause of PM, for
example, biallelic pathogenic variants in ASPM (Table 1), and these
variants were then removed from the analysis (15 alleles). Mutation
burden tests compared the 64 PM patients to 63 control patients.
The patients with PM had a higher number of allelic variants in six
centrosomal PM genes for allelic frequencies of 1% or less (Figure 2).
The statistics for each allelic frequency are shown in Table S3.
In parallel, a mutation burden test was performed with a subset
of ten non‐neural control genes and showed no significant difference
between the cases and the controls (Figure 2).
Results from this second cohort confirmed the significant burden
of PM gene variants in patients with PM and showed the burden to
consist of variants in centrosomal genes.
3.3 | Casc5 invalidation produces a severe MCPH/
Seckel phenotype in zebrafish
To complement our approach in patients with PM, we aimed at
modeling digenic inheritance in zebrafish, and at demonstrating
digenic inheritance specifically with two centrosomal genes, as
opposed to a centrosomal and a non‐centrosomal gene. Therefore,
we used genome editing to invalidate two centrosomal genes (aspm
and wdr62) and one non‐centrosomal gene (casc5), after showing that
these genes were the sole orthologues of human ASPM, WDR62, and
CASC5 in the zebrafish genome (see Supplemental Methods).We first
studied the phenotype in fish with homozygous premature termina-
tion codons in one of the three genes only. Aspm −/− larvae and
wdr62 −/− larvae showed a normal phenotype (p values after the
Kruskal–Wallis test ranging from 0.536 to 0.795). Casc5 −/− larvae
showed a very severe phenotype, detectable from three dpf, and
lethal after five to six dpf. The larvae had a small head and failed to
thrive, with a short and incurvated body (Figure 3). After five to six
dpf, edema developed and the casc5 −/− larvae died. Five distinct
experiments were performed on four to five dpf larvae, using
two different casc5 mutant lines (Table S1). In all five experiments,
casc5 −/− head area and body length were statistically significantly
reduced in comparison to casc5 +/− or wildtype larvae, as observed in
the MCPH/Seckel type of human PM. One representative experi-
ment is shown in Figure 3 (p values after the Kruskal–Wallis test,
p < .001 for head area, p < .001 for body length). The p values after
multiple comparison tests are shown in Table S4.
Our data showed that casc5‐invalidated larvae had a severe
developmental phenotype with microcephaly and short stature, while
by contrast, invalidation of aspm or wdr62 produced no apparent
phenotype in zebrafish.
3.4 | Aspm and wdr62 do not modify the casc5
zebrafish phenotype
All the double heterozygous larvae had a normal phenotype
(aspm +/− wdr62 +/−, aspm +/− casc5 +/−, and casc5 +/− wdr62
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observed in comparison with the wildtype larvae (p values after the
Kruskal–Wallis test ranging from 0.317 to 0.970).
Aspm +/− casc5 +/− crossings revealed an abnormal phenotype only
in aspm +/+ casc5 −/−, aspm +/− casc5 −/−, and aspm −/− casc5 −/− larvae.
The phenotype was the same as in the casc5 monogenic experiments. All
casc5 −/− larvae had a short incurvated body, a small head, and died with
edema after a few days. Aspm −/− casc5 +/− triallelic larvae had a normal
phenotype. One representative experiment out of three is shown in
Figure S2 (p values after Kuskal–Wallis test, p= .001 for head area,
p< .001 for body length). The p values after multiple comparison tests are
shown in Table S5.
Casc5 +/− wdr62 +/− crossings revealed an abnormal phenotype only
in casc5 −/− wdr62 +/+, casc5 −/− wdr62 +/−, and casc5 −/− wdr62 −/−
larvae. Here also, the phenotype was the same as in the casc5monogenic
experiments, all casc5 −/− larvae had a short incurvated body, a small
head, and died after a few days. Casc5 +/− wdr62 −/− triallelic larvae had
a normal phenotype. One representative experiment out of three is
shown in Figure S3 (p values after Kuskal–Wallis test, p< .001 for head
area, p< .001 for body length). The p values after multiple comparison
tests are shown in Table S6.
We thus observed that additional aspm or wdr62 invalidation did not
modify the casc5 phenotype, whether heterozygous or homozygous.
3.5 | Aspm and wdr62 produce a quadriallelic PM
phenotype in zebrafish
Triallelic aspm +/− wdr62 −/− and aspm −/− wdr62 +/− larvae had a
normal phenotype, while quadriallelic aspm −/− wdr62 −/− had a very
F IGURE 1 PM patients carry coding variants in 75 PM genes beyond Mendelian inheritance. (a) Variants in 75 PM genes (left) and in 75
control genes (right) identified via exome sequencing were filtered for allelic frequencies <5% in patients with PM (triangles, n = 47) and in
control patients with non‐neurological disorders (circles, n = 140). The y‐axis shows the number of variants per patient. Variants identified as
monogenic causes of PM in patients with PM (e.g., biallelic pathogenic variants in CEP152) were removed from the total count. Horizontal bars,
mean number of variants. p Values after Wilcoxon test; *p = .028; NS, p = .493. (b) Mean number of allelic variants per patient in 75 PM genes, in
the cases (bottom) and controls (top). The colors represent the distribution of the variants in the different genes. Genes containing no variant in
either group were not represented. p Value after Wilcoxon test; *p = .028. NS, not significant; PM, primary microcephaly
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severe phenotype, lethal after a few days (Figure 4). Quadriallelic fish
presented with a strong reduction in head size, and a shortened body
length. One representative experiment out of three is shown in Figure 4
(p values after Kuskal–Wallis test, p= .006 for head area, p= .018 for
body length). The p values after multiple comparison tests are shown in
Table S7.
We thus observed a severe digenic phenotype in aspm −/− and
wdr62 −/− quadriallelic larvae, while both types of triallelic larvae
displayed a normal phenotype.
3.6 | Candidate gene pairs from PM cohort digenic
analysis
Finally, patients’ results were re‐examined individually, from a digenic
viewpoint, in search of potential cases of double heterozygosity, triallelic,
or quadriallelic inheritance. We observed candidate digenic pairs among
centrosomal genes, including a case of triallelism with ASPM and WDR62
variants, and cases of double heterozygosity and triallelism involving
CEP135 andWDR62, CDK5RAP2 andWDR62, and CDKRAP2 and CEP135
variants. These candidate digenic pairs are listed in Table S8.
4 | DISCUSSION
PM is a usually Mendelian phenotype, often autosomal recessive,
with vast genetic and phenotypic heterogeneity. We hypothesized
that patients with identified or unidentified Mendelian pathogenic
variants also carried a significant burden of less penetrant genetic
variants in other PM‐causing genes, that modified penetrance or
expressivity.
We tested two independent cohorts of unrelated probands with
PM in search for associations with genetic variants in PM genes
beyond simple Mendelian inheritance, by measuring the burden of
variants in a predefined set of PM genes, as compared with control
patients with non‐neurological disorders. A similar approach in
patients with Charcot‐Marie‐Tooth has shown that a genetic burden
contributed to phenotypic variability (Gonzaga‐Jauregui et al., 2015).
We found a significant burden of PM gene variants in patients with
PM and then removed from the analysis all Mendelizing, highly
penetrant variants identified as monogenic causes of PM (e.g.,
biallelic pathogenic variants in CEP152), to correct for the bias that
patients with PM would obviously have more variants in PM genes
because they harbor monogenic pathogenic variants in PM genes.
F IGURE 2 PM patients show a burden of variants in six centrosomal genes. (a) Variants in six centrosomal PM genes (left) and in ten control
genes (right) identified via gene panel deep sequencing in patients with PM (triangles, n = 64) and control patients (circles, n = 63) and filtered
for allelic frequencies <1%. The y‐axis shows the number of variants per patient. Variants identified as monogenic causes of PM in patients with
PM (e.g., biallelic pathogenic variants in ASPM) were removed from the count. Horizontal bars, mean number of variants. p Values after
Wilcoxon test; *p = .039; NS, p = .293. (b) Mean number of allelic variants per patient in six centrosomal genes, in the cases (bottom) and controls
(top). The colors represent the distribution of the variants in the different genes. p Value after Wilcoxon test; *p = .039. NS, not significant; PM,
primary microcephaly
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PM patients harboring only non‐Mendelizing variants were also
included in the analysis. In control experiments, we tested PM and
non‐PM patients for a burden of variants in non‐PM genes, and
observed no difference between the two groups.
In the exome cohort, patients with PM carried coding variants in
75 PM genes beyond Mendelian inheritance. Indeed, after monogenic
causes of PM were removed from the analysis, an excess of PM gene
variants persisted in the patients with PM in comparison with control
patients, strongly suggesting a mode of inheritance more complex
than simply Mendelian. Conversely, patients with PM and non‐PM
showed the same amount of variants in 75 randomly chosen control,
housekeeping genes, and a permutation test confirmed that the
significance we observed was not due to chance in the selection of
the 75 control genes. The difference between cases and controls was
highest when the PM variants were filtered for a 5% allelic
frequency, which is compatible with oligogenic inheritance within
the 75 PM genes (Manolio et al., 2009). In the gene panel cohort,
patients with PM showed a burden of variants in six centrosomal
genes even after removing the variants identified to cause PM on a
Mendelian basis. The difference between cases and controls was
highest when the variants were filtered with a 1% allelic frequency,
which is compatible with digenic inheritance within the six genes of
the panel. Most variants involved in rare digenic diseases are rare
(allelic frequency <1%) and their gene products interact directly or
indirectly (Gazzo et al., 2016). Oligogenic or multigenic inheritance
cannot involve rare variants only, because such combinations would
be exceedingly rare (Manolio et al., 2009). Our observations thus
suggest the existence of a digenic mode of inheritance in human PM,
involving centrosomal genes.
Zebrafish studies were performed to validate digenic inheritance in
another, holistic model, and to query molecular interactions between
putative centrosomal or non‐centrosomal PM genes. We chose casc5 as a
paradigm of the non‐centrosomal gene. Contrary to ASPM and WDR62,
CASC5 is expressed at the kinetochore and is required for chromatin
F IGURE 3 Casc5 invalidation produces a severe MCPH/Seckel phenotype in zebrafish. (a) Live images of casc5 +/+ (top) and casc5 −/−
(bottom) larvae. Dorsal views (left) show a reduced head size in casc5 −/−. Lateral views (right) of whole larvae show a reduced body length in
casc5 −/−. Casc5 −/− larvae are severely malformed and die after a few days. Bars = 500 μm. (b) Head area (mm2, left) and body length (mm,
right) of the larvae. n = 76. p Values after Dunnʼs posttest; ***p < .001; NS, p ≥ .050. One representative experiment out of five. C, casc5; MCPH,
microcephaly primary hereditary; NS, not significant
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attachment to the mitotic apparatus (Kiyomitsu et al., 2007). First, we had
to study monogenic invalidation of casc5 in the zebrafish, which had not
been reported. Our casc5 −/− zebrafish displayed a severe MCPH‐like
phenotype, consisting of a reduction in head size and body length, which
was consistent with the human CASC5 phenotype. Indeed, all patients
with CASC5 biallelic pathogenic variants presented with congenital
microcephaly and short stature (Saadi et al., 2016). The phenotype in
zebrafish was very severe, lethal after a few days, while the human
patients survive into adulthood. This is compatible with the fact that the
genome‐edited zebrafish alleles were null, while the pathogenic splicing
variants observed in patients likely result in hypomorphic alleles (Genin
et al., 2012). To our knowledge, we here report the first zebrafish model
for CASC5 invalidation.
Our genome‐edited aspm −/− and wdr62 −/− zebrafish displayed a
normal phenotype. However, knocking down each of these genes
using morpholinos had previously produced a reduction in head and
eye sizes in zebrafish larvae (Kim et al., 2011; Novorol et al., 2013).
This discrepancy may be due to a genetic compensation triggered by
the gene invalidations but not by the morpholinos (El‐Brolosy et al.,
2019). Quadriallelic aspm −/− wdr62 −/− were severely affected,
demonstrating digenic inheritance, consistent with direct protein
interaction at the centrosome as observed in mice (Jayaraman et al.,
2016). Conversely, the casc5 +/− or −/− phenotypes were not
modified by additional aspm or wdr62 invalidation. Our observations
thus provide human and zebrafish in vivo evidence for genetic
interaction between aspm and wdr62, and absence of genetic
interaction between either apsm or wdr62 and casc5, consistent with
distinct pathways being involved in the pathogeny of PM.
The distinction between digenic inheritance and dual molecular
diagnoses with extensively, if not completely, overlapping pheno-
types (Posey et al., 2017) is not simple. We observed no patient with
two definite molecular diagnoses in our cohort (e.g., Mendelizing,
F IGURE 4 Aspm and wdr62 produce a quadriallelic PM phenotype in zebrafish. (a) Live images of aspm +/+ wdr62 +/+ (top) and aspm −/−
wdr62 −/− (bottom) larvae. Dorsal views (left) show a strongly reduced head size in aspm −/− wdr62 −/−. Lateral views (right) of whole larvae
show a reduced body length in aspm −/− wdr62 −/−. Bars = 500 μm. (b) Head area (mm2, left) and body length (mm, right) of the larvae. n = 177.
p Values after Dunnʼs posttest; *p < .050; NS, p ≥ .050. One representative experiment out of three. A, aspm; NS, not significant; PM, primary
microcephaly; W, wdr62
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biallelic pathogenic variants in ASPM and in WDR62), which
indicates that dual diagnoses are unlikely to be frequent in patients
with PM. Our findings hence support genuine digenic inheritance,
either true digenic, or composite class digenic, inheritance (see
below). Furthermore, the quadriallelic phenotype observed in aspm
−/− wdr62 −/− fish also indicates digenic inheritance, as both
biallelic mutants had normal phenotypes. In humans, digenic
inheritance might take the form of double heterozygosity within
the cases that have no molecular diagnosis under the current
Mendelian model and correspond to true digenic inheritance. Other
patients harbor triallelic variants, consisting of the previously
identified biallelic variants and an additional heterozygous variant
at a second PM locus, suggesting composite class digenic inheri-
tance. In the absence of the third variant, the biallelic variants
would presumably produce a milder phenotype, and it would be
interesting to test this hypothesis in mildly affected siblings of
familial cases. Of note, some PM probands with double hetero-
zygosity might in fact correspond to triallelism with a second,
unidentified mutation at one of the two loci.
We replicated the patients with PM study in an independent
cohort of patients with PM using a more focused genetic approach
consisting of a PM gene panel analysis and confirmed an excess of
variants in PM genes, which furthermore clustered within centrosomal
genes. In this cohort, only 14 PM genes were sequenced, with a very
high—diagnostic‐grade—coverage (>200X mean coverage), while in the
exome cohort, the coverage was much lower (85X mean coverage) and
varied across the exome.
We also performed a mutation burden test in the subset of six
centrosomal genes in the exome cohort, but this was not significant,
probably because of insufficient coverage resulting in an incomplete
detection of variants in the exome data, and also, mainly, because we
had to restrict the analysis to gene exons present in the intersection
of the five different kits used by the different exome sequencing
platforms (see Supplemental Methods).
More generally, several elements reduced the power of our mutation
burden tests. First, our exome data were technically heterogeneous
because DNA sequencing was performed at different places and times.
Five different DNA capture kits were used, so we had to restrict our
analysis to the variants included in the intersection of the five methods,
which decreased the total number of variants by a factor two. Second,
both in the exome and in the panel cohorts, we removed all the variants
identified as monogenic causes of PM. This concerned a limited number
of patients, nine out of 47 exome patients and eight out of 64 panel
patients, since a number of patients with PM referred to our two genetic
centers had been previously diagnosed with ASPM or WDR62 biallelic
pathogenic variants by Sanger sequencing and were hence not further
tested in our panel nor exome cohort. But even if removed from the
count, these variants identified as monogenic causes could also have
taken part in a digenic (triallelic) or even oligogenic inheritance. Third, the
number of patients included in each group was limited because PM is a
rare phenotype.
Taken together, our data strongly suggest that clinically ascer-
tained PM probands harbor a burden of variants in pathway‐specific
PM‐related genes, either in addition to a recognized Mendelian cause
or in a more complex combination. Our findings validate in human
patients the experimental genetic interactions observed in mice
(Jayaraman et al., 2016). This validation is important because a very
large brain is an essentially human feature and PM is an essentially
human phenotype, difficult to modelize in animals.
New machine‐learning methods, like the variant combination
pathogenicity predictor (Papadimitriou et al., 2019), which predicts
the pathogenicity of any bilocus variant combination using a variant
list from a single individual, might be used to re‐examine data from
unsolved PM cases in search of variants in two genes known or
suspected to interact. Putative interactions could then be validated in
zebrafish.
In conclusion, we present the first study bringing to light the
complex background of the apparent Mendelian phenotype of human
PM, delineating centrosomal, and non‐centrosomal pathways, and
show an efficient way to validate digenic interactions in PM using
genome‐edited zebrafish.
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